COMPANY

EicOsis

HQ: Covina, CA source · eicosis.com ↗ · West Coast

Keywords: neuropathic pain

Location: Covina, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

13NIH grants

Funding and NIH signals

NIH award NIH awarded $2.38M (NIH grant 5UH3DA048767-05, continuation, notice Jan 29, 2026). NIH RePORTER 5UH3DA048767-05 (Jan 29, 2026)
Evidence (1 event)
- Jan 29, 2026 · NIH RePORTER 5UH3DA048767-05
  Organization: EICOSIS, LLC; City/State: Davis, CA; Project number: 5UH3DA048767-05; Activity code: UH3; Fiscal year: 2026; Award notice date: 2026-01-29; FY total cost (award amount): 2377268; Administering IC: National Institute on Drug Abuse; Project title: Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Jan 29, 2026 Grant Government grant — NIH UH3: $2.38M (annual award, as published), announced Jan 29, 2026. Agency: NIH/NIDA. Source: government award database. source ↗
Jan 8, 2025 Grant Government grant — NIH UH3: $2.48M (annual award, as published), announced Jan 8, 2025. Agency: NIH/NIDA. Source: government award database. source ↗

Funding

Last 2 years.

Jan 29, 2026 Government grant — NIH UH3: $2.38M (annual award, as published), announced Jan 29, 2026. Agency: NIH/NIDA. Source: government award database. source ↗
Jan 8, 2025 Government grant — NIH UH3: $2.48M (annual award, as published), announced Jan 8, 2025. Agency: NIH/NIDA. Source: government award database. source ↗

NIH awards 13

Annual award amounts. Total $10.9M.

Dec 18, 2023 NIH award 4UH3DA048767-03 FY2024: $2,141,943 awarded for that fiscal year; activity UH3 (OTHER_NIH); PI CORTES-PUCH, IRENE; recipient as written: EICOSIS, LLC, Davis, CA. Development of a Soluble Epoxide Hydrolase In source ↗
Jun 30, 2022 NIH award 1R43HL164226-01 FY2022: $279,136 awarded for that fiscal year; activity R43 (SBIR); PI CORTES-PUCH, IRENE; recipient as written: EICOSIS, LLC, Davis, CA. Identification of mechanism-based therapies to treat source ↗
Aug 19, 2020 NIH award 5UG3DA048767-02 FY2020: $3,046,519 awarded for that fiscal year; activity UG3 (OTHER_NIH); PI BUCKPITT, ALAN R; recipient as written: EICOSIS, LLC, Davis, CA. Development of a Soluble Epoxide Hydrolase Inhi source ↗
Sep 27, 2019 NIH award 1UG3DA048767-01 FY2019: $3,036,135 awarded for that fiscal year; activity UG3 (OTHER_NIH); PI BUCKPITT, ALAN R; recipient as written: EICOSIS, LLC, Davis, CA. Development of a Soluble Epoxide Hydrolase Inhi source ↗
Sep 25, 2019 NIH award 1R43CA233371-01A1 FY2019: $268,196 awarded for that fiscal year; activity R43 (SBIR); PI BUCKPITT, ALAN R; recipient as written: EICOSIS, LLC, Davis, CA. Inhibiting soluble epoxide hydrolase as a treatment source ↗
May 19, 2017 NIH award 3R44ES025598-03S1 FY2017: $1,382 awarded for that fiscal year; activity R44 (SBIR); PI BUCKPITT, ALAN R; recipient as written: EICOSIS, LLC, Davis, CA. sEH Inhibitors to Treat Neuropathic Pain source ↗
May 5, 2017 NIH award 4UH3NS094258-02 FY2017: $125,246 awarded for that fiscal year; activity UH3 (OTHER_NIH); PI BUCKPITT, ALAN R; recipient as written: EICOSIS, LLC, Davis, CA. Development of an Oral Analgesic for Neuropathic source ↗
Feb 28, 2017 NIH award 5R44ES025598-03 FY2017: $705,128 awarded for that fiscal year; activity R44 (SBIR); PI BUCKPITT, ALAN R; recipient as written: EICOSIS, LLC, Davis, CA. sEH Inhibitors to Treat Neuropathic Pain source ↗
Sep 9, 2016 NIH award 3R44ES025598-02S1 FY2016: $76,094 awarded for that fiscal year; activity R44 (SBIR); PI BUCKPITT, ALAN R; recipient as written: EICOSIS, LLC, Davis, CA. sEH Inhibitors to Treat Neuropathic Pain source ↗
Jul 15, 2016 NIH award 3UH2NS094258-01S1 FY2016: $49,999 awarded for that fiscal year; activity UH2 (OTHER_NIH); PI BUCKPITT, ALAN R; recipient as written: EICOSIS, LLC, Davis, CA. Development of an Oral Analgesic for Neuropathic source ↗
Feb 25, 2016 NIH award 2R44ES025598-02 FY2016: $731,876 awarded for that fiscal year; activity R44 (SBIR); PI BUCKPITT, ALAN R; recipient as written: EICOSIS, LLC, Davis, CA. sEH Inhibitors to Treat Neuropathic Pain source ↗
Dec 15, 2015 NIH award 1UH2NS094258-01 FY2016: $224,163 awarded for that fiscal year; activity UH2 (OTHER_NIH); PI BUCKPITT, ALAN R; recipient as written: EICOSIS, LLC, Davis, CA. Development of an Oral Analgesic for Neuropathic source ↗
Sep 22, 2014 NIH award 1R43ES025598-01A1 FY2014: $224,443 awarded for that fiscal year; activity R43 (SBIR); PI BUCKPITT, ALAN R; recipient as written: EICOSIS, LLC, Davis, CA. sEH Inhibitors to Treat Neuropathic Pain source ↗